Evaluation of biorelevant in vitro test for carbamazepine controlled release tablets based on in vivo results
- At: 2008 FIP Congress in Basel (Switzerland)
- Type: Poster
- By: HOMSEK, Irena (Galenika ad, Belgrade, Yugoslavia)
- Co-author(s): Cvetkovic, Nebojsa (Galenika ad, BELGRADE, Serbia)
Simic, Slobodanka (Galenika ad, BELGRADE, Serbia)
An important aspect of the development of a pharmaceutical product is to find an in vitro characteristic of the chosen formulation that reflects its in vivo performance. The products investigated were the two controlled release tablets, having carbamazepine as an active ingredient in dose of 400 mg. In vivo plasma concentration data were obtained.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.